Gene · 4860
PNP: purine nucleoside phosphorylase
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. PNP: purine nucleoside phosphorylase. Genes, record 4860. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4860
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P00491 | Purine nucleoside phosphorylase | 289 | 41 | Ensembl, GeneID, HGNC |
Source UniProt
Patents53
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026067851 A | 2026-04-21 | 363 | P00491 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 60465 | P00491 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 7882 | P00491 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 10591 | P00491 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7394 | P00491 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7394 | P00491 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 7882 | P00491 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 33795 | P00491 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 10591 | P00491 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 10591 | P00491 | Espacenet |
1 to 10 of 53
See all 53 patentsDrugs3
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
Trials18
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT01776411 | FORODESINE | PHASE1/PHASE2 | ClinicalTrials.gov | |
| NCT01407874 | ULODESINE | PHASE2 | ClinicalTrials.gov | |
| NCT01265264 | ULODESINE | PHASE2 | ClinicalTrials.gov | |
| NCT01129648 | ULODESINE | PHASE2 | ClinicalTrials.gov | |
| NCT00985127 | ULODESINE | PHASE2 | ClinicalTrials.gov | |
| NCT00823355 | FORODESINE | PHASE1 | ClinicalTrials.gov | |
| NCT00742495 | FORODESINE | PHASE1/PHASE2 | ClinicalTrials.gov | |
| NCT00646165 | FORODESINE | PHASE1 | ClinicalTrials.gov | |
| NCT00640523 | FORODESINE | PHASE2 | ClinicalTrials.gov | |
| NCT00501735 | FORODESINE | PHASE2 | ClinicalTrials.gov |
1 to 10 of 18
See all 18 trialsNIH grants1,683
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PNP papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 7 | 2025 |
| P30CA013330 | Cancer Center Support Grant | 5 | 2025 |
| P30ES009089 | Center for Environmental Health in Northern Manhattan | 5 | 2025 |
| R01GM121441 | Earth abundant catalysts as an enabling tool for organic synthesis | 5 | 2025 |
| ZIAAI001222 | Characterization of the cellular and molecular bases of inborn errors of immunity | 5 | 2025 |
| K12GM102779 | Bronx-Einstein Training in Teaching and Research (BETTR), an IRACDA program | 4 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 4 | 2025 |
| P41EB017183 | Center for Advanced Imaging Innovation and Research (CAI2R) | 4 | 2025 |
| R13AI094943 | Annual Primary Immune Deficiency Treatment Consortium (PIDTC) Workshop and Education Day | 4 | 2025 |
| R35GM145213 | Protein dynamics from femtoseconds to milliseconds as crafted by natural and laboratory evolution: towards enzyme design | 4 | 2025 |
1 to 10 of 1,683Source NIH's project files
See all 1,683 nih grantsPapers3,553
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathway and Mechanism for the Biodegradation of Inosine and Guanosine by Heyndrickxia coagulans NJ01. | Foods | 2026 | 42794039 | PubTator, text mining | PubMed |
| Integrated transcriptomics and metabolomics reveal suppression of the PPAR α/γ pathway linking purine metabolism disorder to high-protein diet-induced hyperuricemia in goslings. | Anim Nutr | 2026 | 42741484 | PubTator, text mining | PubMed |
| Exploring Novel Indazole and Pyrazole Nucleoside Analogues: Enzymatic Synthesis, Characterization, and Biological Evaluation. | Int J Mol Sci | 2026 | 42737455 | PubTator, text mining | PubMed |
| Purine nucleoside phosphorylase in breast cancer from metabolic regulation to targeted therapy: challenges and opportunities. | RSC Med Chem | 2026 | 42689267 | PubTator, text mining | PubMed |
| Mid-life candidate vascular plasma biomarkers are associated with MRI markers of vascular brain injury and amyloid- and tau-PET in cognitively healthy adults. | J Alzheimers Dis | 2026 | 42669799 | PubTator, text mining | PubMed |
| Cadmium-associated cognitive impairment in adults: Proteomics-guided blood-based risk stratification with external validation and rat multimodal corroboration. | Environ Pollut | 2026 | 42641860 | PubTator, text mining | PubMed |
| Extending Chain Length of PNP Pincer Ligands Triggers Catalytic Activity of Gold-Copper Nanoclusters in Aerobic Oxidations. | Angew Chem Int Ed Engl | 2026 | 42585034 | PubTator, text mining | PubMed |
| Repurposing nucleos(t)ide analogs as purine nucleoside phosphorylase inhibitors through Gaussian accelerated molecular dynamics simulations. | Biochem Biophys Res Commun | 2026 | 42580172 | PubTator, text mining | PubMed |
| Proton motive force as a driver of persister sensitization by adenosine. | J Biol Chem | 2026 | 42567508 | PubTator, text mining | PubMed |
| Comprehensive analysis of the association between perfluorooctanoic acid exposure and osteosarcoma progression. | Food Chem Toxicol | 2026 | 42462996 | PubTator, text mining | PubMed |
1 to 10 of 3,553
See all 3,553 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4860
GET https://conductscience.org/api/genes/v1/4860/patents?page=2